IL127595A - Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use - Google Patents

Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use

Info

Publication number: IL127595A
Authority: IL; Israel
Prior art keywords: rhesus; preparation; antigen binding; antigens; specificity
Prior art date: 1996-06-24

Application number

IL12759597A

Other languages

English (en)

Other versions

IL127595A0 (en

Original Assignee

Zlb Behring Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-24

Filing date

1997-06-20

Publication date

2005-09-25

1997-06-20 Application filed by Zlb Behring Ag filed Critical Zlb Behring Ag

1999-10-28 Publication of IL127595A0 publication Critical patent/IL127595A0/xx

2005-09-25 Publication of IL127595A publication Critical patent/IL127595A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/80—Antibody or fragment thereof whose amino acid sequence is disclosed in whole or in part
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Hematology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Urology & Nephrology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Cell Biology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Analytical Chemistry (AREA)
Food Science & Technology (AREA)
General Physics & Mathematics (AREA)
Epidemiology (AREA)
General Engineering & Computer Science (AREA)
Pathology (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Plant Pathology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)

IL12759597A 1996-06-24 1997-06-20 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use IL127595A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP96810421		1996-06-24
PCT/EP1997/003253 WO1997049809A1 (en)	1996-06-24	1997-06-20	Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use

Publications (2)

Publication Number	Publication Date
IL127595A0 IL127595A0 (en)	1999-10-28
IL127595A true IL127595A (en)	2005-09-25

Family

ID=8225636

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12759597A IL127595A (en)	1996-06-24	1997-06-20	Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use

Country Status (23)

Country	Link
US (3)	US7038020B1 (hu)
EP (1)	EP0920509B1 (hu)
JP (1)	JP3841360B2 (hu)
KR (1)	KR100361449B1 (hu)
AT (1)	ATE272116T1 (hu)
AU (1)	AU722127B2 (hu)
BG (1)	BG64534B1 (hu)
BR (1)	BR9709958A (hu)
CA (1)	CA2258494C (hu)
CZ (1)	CZ296807B6 (hu)
DE (1)	DE69730031T2 (hu)
DK (1)	DK0920509T3 (hu)
ES (1)	ES2224255T3 (hu)
HU (1)	HUP9902605A3 (hu)
IL (1)	IL127595A (hu)
IS (1)	IS2220B (hu)
NO (1)	NO327947B1 (hu)
NZ (1)	NZ333329A (hu)
PL (1)	PL186019B1 (hu)
RU (1)	RU2204602C2 (hu)
SK (1)	SK284879B6 (hu)
TR (1)	TR199802692T2 (hu)
WO (1)	WO1997049809A1 (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1131428A2 (en) *	1998-11-19	2001-09-12	Incyte Pharmaceuticals, Inc.	Immunoglobulin superfamily proteins
EP1106625A1 (en) *	1999-11-17	2001-06-13	ZLB Bioplasma AG	Rhesus D specific peptide sequences
FR2807767B1 (fr)	2000-04-12	2005-01-14	Lab Francais Du Fractionnement	Anticorps monoclonaux anti-d
DK1276855T3 (da) *	2000-04-17	2012-11-26	Dyax Corp	Fremgangsmåde til konstruktion af visningsbiblioteker over genetiske pakker for medlemmer af en diversificeret peptidfamilie
US8288322B2 (en)	2000-04-17	2012-10-16	Dyax Corp.	Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
US20030049731A1 (en) *	2000-12-05	2003-03-13	Bowdish Katherine S.	Engineered plasmids and their use for in situ production of genes
ATE498718T1 (de)	2000-12-18	2011-03-15	Dyax Corp	Gerichtete bibliotheken die genetisch verpackt sind
AU2016225923B2 (en) *	2001-04-17	2018-07-05	Takeda Pharmaceutical Company Limited	Novel Methods of Constructing Libraries Comprising Displayed and/or Expressed Members of a Diverse Family of Peptides, Polypeptides or Proteins and the Novel Libraries
RU2209434C1 (ru) *	2001-11-15	2003-07-27	Российский центр судебно-медицинской экспертизы Министерства здравоохранения Российской Федерации	Способ получения резус-пептидов анти-d, специфически выявляющих антиген rhd в следах крови и выделений
US20040067532A1 (en)	2002-08-12	2004-04-08	Genetastix Corporation	High throughput generation and affinity maturation of humanized antibody
ATE443870T1 (de)	2004-07-20	2009-10-15	Symphogen As	Verfahren zur charakterisierung einer polyklonalen zellinie
NZ552265A (en) *	2004-07-20	2009-04-30	Symphogen As	Anti-rhesus D recombinant polyclonal antibody and methods of manufacture
GB0706558D0 (en) *	2007-04-03	2007-05-09	Common Services Agency For The	Diagnostic assay
US8877688B2 (en)	2007-09-14	2014-11-04	Adimab, Llc	Rationally designed, synthetic antibody libraries and uses therefor
CA3187687A1 (en)	2007-09-14	2009-03-19	Adimab, Llc	Rationally designed, synthetic antibody libraries and uses therefor
US12529164B2 (en)	2007-09-14	2026-01-20	Adimab, Llc	Rationally designed, synthetic antibody libraries and uses therefor
US20090093004A1 (en)	2007-10-04	2009-04-09	Symphogen A/S	Potency assay
WO2009114815A1 (en)	2008-03-13	2009-09-17	Dyax Corp	Libraries of genetic packages comprising novel hc cdr3 designs
CA2968164C (en)	2008-04-24	2019-08-20	Dyax Corp.	Libraries of genetic packages comprising novel hc cdr1, cdr2, and cdr3 and novel lc cdr1, cdr2, and cdr3 designs
KR102318383B1 (ko)	2010-07-16	2021-10-27	아디맵 엘엘씨	항체 라이브러리
CA2888211A1 (en) *	2012-11-06	2014-05-15	Medimmune, Llc	Combination therapies using anti-pseudomonas psl and pcrv binding molecules
JP7278270B2 (ja) *	2017-10-20	2023-05-19	シーエスエル、リミテッド	方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2127434A (en)	1982-09-17	1984-04-11	Univ London	A human monoclonal antibody against Rhesus D antigen
GB8722018D0 (en) *	1987-09-18	1987-10-28	Central Blood Lab Authority	Human anti-rh(d)monoclonal antibodies
GB8925590D0 (en)	1989-11-13	1990-01-04	Central Blood Lab Authority	Monoclonal antibodies

1997
- 1997-06-20 ES ES97929244T patent/ES2224255T3/es not_active Expired - Lifetime
- 1997-06-20 RU RU99101121/13A patent/RU2204602C2/ru not_active IP Right Cessation
- 1997-06-20 DE DE69730031T patent/DE69730031T2/de not_active Expired - Lifetime
- 1997-06-20 BR BR9709958A patent/BR9709958A/pt not_active Application Discontinuation
- 1997-06-20 CA CA002258494A patent/CA2258494C/en not_active Expired - Fee Related
- 1997-06-20 KR KR10-1998-0710975A patent/KR100361449B1/ko not_active Expired - Fee Related
- 1997-06-20 AU AU33423/97A patent/AU722127B2/en not_active Expired
- 1997-06-20 AT AT97929244T patent/ATE272116T1/de active
- 1997-06-20 US US09/147,443 patent/US7038020B1/en not_active Expired - Fee Related
- 1997-06-20 CZ CZ0395998A patent/CZ296807B6/cs not_active IP Right Cessation
- 1997-06-20 JP JP50232398A patent/JP3841360B2/ja not_active Expired - Lifetime
- 1997-06-20 SK SK1761-98A patent/SK284879B6/sk not_active IP Right Cessation
- 1997-06-20 HU HU9902605A patent/HUP9902605A3/hu unknown
- 1997-06-20 NZ NZ333329A patent/NZ333329A/xx not_active IP Right Cessation
- 1997-06-20 TR TR1998/02692T patent/TR199802692T2/xx unknown
- 1997-06-20 IL IL12759597A patent/IL127595A/xx not_active IP Right Cessation
- 1997-06-20 WO PCT/EP1997/003253 patent/WO1997049809A1/en not_active Ceased
- 1997-06-20 DK DK97929244T patent/DK0920509T3/da active
- 1997-06-20 PL PL97330794A patent/PL186019B1/pl not_active IP Right Cessation
- 1997-06-20 EP EP97929244A patent/EP0920509B1/en not_active Expired - Lifetime
1998
- 1998-12-11 IS IS4922A patent/IS2220B/is unknown
- 1998-12-15 BG BG103016A patent/BG64534B1/bg unknown
- 1998-12-23 NO NO19986088A patent/NO327947B1/no not_active IP Right Cessation
2005
- 2005-06-20 US US11/155,775 patent/US7399471B2/en not_active Expired - Fee Related
2006
- 2006-01-18 US US11/333,197 patent/US7429647B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0920509B1 (en)	2004-07-28
TR199802692T2 (xx)	1999-03-22
US7399471B2 (en)	2008-07-15
CZ395998A3 (cs)	1999-05-12
IS4922A (is)	1998-12-11
WO1997049809A1 (en)	1997-12-31
RU2204602C2 (ru)	2003-05-20
ES2224255T3 (es)	2005-03-01
NO986088D0 (no)	1998-12-23
DE69730031D1 (de)	2004-09-02
PL330794A1 (en)	1999-06-07
HUP9902605A2 (hu)	1999-11-29
EP0920509A1 (en)	1999-06-09
SK176198A3 (en)	1999-07-12
US20060165694A1 (en)	2006-07-27
US7038020B1 (en)	2006-05-02
SK284879B6 (sk)	2006-01-05
ATE272116T1 (de)	2004-08-15
HUP9902605A3 (en)	2001-11-28
JP3841360B2 (ja)	2006-11-01
JP2000515732A (ja)	2000-11-28
KR20000022530A (ko)	2000-04-25
CA2258494C (en)	2008-05-27
CA2258494A1 (en)	1997-12-31
BG64534B1 (bg)	2005-06-30
NZ333329A (en)	2000-07-28
US20050266013A1 (en)	2005-12-01
NO327947B1 (no)	2009-10-26
NO986088L (no)	1999-02-24
DE69730031T2 (de)	2005-06-16
CZ296807B6 (cs)	2006-06-14
KR100361449B1 (ko)	2003-01-24
PL186019B1 (pl)	2003-09-30
DK0920509T3 (da)	2004-12-06
AU722127B2 (en)	2000-07-20
IS2220B (is)	2007-03-15
US7429647B2 (en)	2008-09-30
BR9709958A (pt)	1999-08-10
AU3342397A (en)	1998-01-14
BG103016A (en)	1999-08-31
IL127595A0 (en)	1999-10-28

Publication	Publication Date	Title
IL127595A (en)	2005-09-25	Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use
WO1998050547A3 (en)	1999-03-11	Human toll-like receptor proteins, related reagents and methods
AU4230493A (en)	1993-11-29	Diphtheria toxin receptor-binding region
NZ503763A (en)	2003-01-31	Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
EP0434713A4 (en)	1992-05-20	Hiv-1 envelope muteins lacking hypervariable domains
IL138424A0 (en)	2001-10-31	Covalently reactive antigen analogs and pharmaceutical compositions containing the same
WO1997008318A3 (en)	1997-04-17	Compounds and methods for treatment and diagnosis of prostate cancer
ZA891861B (en)	1989-11-29	Monoclonal antibodies
CA2068222A1 (en)	1991-05-14	Monoclonal antibodies
WO1996021734A3 (en)	1996-11-28	P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
EP1433792A8 (en)	2004-10-06	Human receptor proteins, related reagents and methods
WO2003003986A3 (en)	2004-07-01	Parathyroid hormone antibodies and related methods
WO2001057219A3 (en)	2002-03-07	Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
EP0177814A3 (en)	1987-12-02	Peptide antibodies and their use in detecting oncogene products
AU641736B2 (en)	1993-09-30	Delivery of agents
WO2002051237A3 (en)	2004-02-26	Helicobacter proteins, nucleic acids and uses thereof
WO1999019480A3 (en)	1999-06-24	Human receptor proteins; related reagents and methods
WO2000017363A3 (en)	2000-07-20	Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses
ES2092960A1 (es)	1996-12-01	Gen de la proteina 1 de union a transferrina (tbp1) de actinobacillus pleuropneumoniae, utilizacion de esta en la preparacion de productos para la vacunacion contra la pleuroneumonia y en reactivos de diagnostico.
BG48880A1 (en)	1991-06-14	Hybrodomic cell line mus musculus b 6/3, secretizing monoclonal antibodies against rickettsia conorii

Legal Events

Date	Code	Title
2006-06-18	KB	Patent renewed
2007-07-24	KB	Patent renewed
2016-01-31	MM9K	Patent not in force due to non-payment of renewal fees